Capio Biosciences

Pre-clinical

Cambridge, United StatesFounded 2019capiobiosciences.com

Capio Biosciences goal is to improve cancer patient outcomes by developing advanced oncology diagnostics. Circulating Tumor Cells are robust biomarkers.

Market Cap

Private

Pipeline

—

Patents

—

Publications

—

Private Company

Funding information not available

About

Capio Biosciences goal is to improve cancer patient outcomes by developing advanced oncology diagnostics. Circulating Tumor Cells are robust biomarkers.

Diagnostics